Suppr超能文献

运用流式细胞术检测微小残留病:在急性白血病中的应用

Minimal residual disease detection using flow cytometry: Applications in acute leukemia.

作者信息

Chatterjee T, Mallhi R S, Venkatesan S

机构信息

Commandant, 166 Military Hospital, C/o 56 APO, India.

Professor, Department of Immunohaematology & Blood Transfusion, Armed Forces Medical College, Pune 411040, India.

出版信息

Med J Armed Forces India. 2016 Apr;72(2):152-6. doi: 10.1016/j.mjafi.2016.02.002. Epub 2016 Mar 29.

Abstract

Minimal residual disease (MRD) describes disease that can be diagnosed by methodologies other than conventional morphology, and includes molecular methods (like polymerase chain reaction (PCR)) or flow cytometry (FCM). Detection and monitoring of MRD is becoming the standard of care, considering its importance in predicting the treatment outcome. MRD aids in identifying high-risk patients and hence therapy can be intensified in them while deintensification of therapy can prevent long-term sequelae of chemotherapy in low-risk category. FCM is considered as a less labor-intensive and faster MRD technique as compared to PCR although it has its own share of disadvantages. Current immune-based methodologies for detection of MRD depend on establishing leukemia-associated aberrant immunophenotype (LAIP), at diagnosis or relapse and use this information at specified time points for detection of MRD, or apply a standardized panel of antibody combinations for all MRD cases, in a different-from-normal approach. This review highlights MRD detection by FCM and its application in acute leukemia.

摘要

微小残留病(MRD)指的是可通过传统形态学以外的方法诊断出的疾病,包括分子方法(如聚合酶链反应(PCR))或流式细胞术(FCM)。鉴于MRD在预测治疗结果方面的重要性,对其进行检测和监测正成为治疗的标准。MRD有助于识别高危患者,因此可对他们强化治疗,而对于低风险患者,减少治疗强度可预防化疗的长期后遗症。与PCR相比,FCM被认为是一种劳动强度较低且速度更快的MRD检测技术,尽管它也有自身的缺点。目前基于免疫的MRD检测方法依赖于在诊断或复发时确定白血病相关异常免疫表型(LAIP),并在特定时间点利用该信息检测MRD,或者以一种不同于正常情况的方法,为所有MRD病例应用标准化的抗体组合面板。本综述重点介绍了通过FCM检测MRD及其在急性白血病中的应用。

相似文献

1
Minimal residual disease detection using flow cytometry: Applications in acute leukemia.
Med J Armed Forces India. 2016 Apr;72(2):152-6. doi: 10.1016/j.mjafi.2016.02.002. Epub 2016 Mar 29.
5
[Prognostic Analysis of Minimal Residual Disease from Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplant by Flow Cytometry].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb;26(1):239-244. doi: 10.7534/j.issn.1009-2137.2018.01.042.
8
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Leukemia. 2013 Mar;27(3):635-41. doi: 10.1038/leu.2012.231. Epub 2012 Aug 16.

引用本文的文献

2
Minimal Residual Disease Detection: Implications for Clinical Diagnosis and Cancer Patient Treatment.
MedComm (2020). 2025 May 15;6(6):e70193. doi: 10.1002/mco2.70193. eCollection 2025 Jun.
3
Enhancing reproducibility in single cell research with biocytometry: An inter-laboratory study.
PLoS One. 2024 Dec 9;19(12):e0314992. doi: 10.1371/journal.pone.0314992. eCollection 2024.
4
CD38 and CD58: A Gallant Savior in Under-Resourced Laboratories.
Cureus. 2024 Nov 4;16(11):e72968. doi: 10.7759/cureus.72968. eCollection 2024 Nov.
7
Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry.
Oman Med J. 2021 Nov 30;36(6):e323. doi: 10.5001/omj.2021.108. eCollection 2021 Nov.
8
Small molecular fluorescence dyes for immuno cell analysis.
Anal Biochem. 2021 Feb 1;614:114063. doi: 10.1016/j.ab.2020.114063. Epub 2020 Dec 9.
9
Evaluating measurable residual disease in acute myeloid leukemia.
Blood Adv. 2018 Jun 12;2(11):1356-1366. doi: 10.1182/bloodadvances.2018016378.
10
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system.
Cytometry A. 2017 Oct;91(10):952-965. doi: 10.1002/cyto.a.23148. Epub 2017 Jun 13.

本文引用的文献

1
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.
Blood. 2015 Jun 25;125(26):3996-4009. doi: 10.1182/blood-2015-03-580027. Epub 2015 May 21.
3
Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.
J Clin Oncol. 2014 Apr 20;32(12):1218-27. doi: 10.1200/JCO.2013.51.1055. Epub 2014 Mar 17.
6
Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
Cytometry B Clin Cytom. 2012 Jul;82(4):252-8. doi: 10.1002/cyto.b.21017. Epub 2012 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验